Harvard to Close Primate Center

The NIH-funded New England Primate Research Center is to be shuttered after 50 years of operation because of the grim outlook for federal funding.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A cotton-top tamarinWIKIMEDIA, CUATROCK77Harvard Medical School this week announced that it will shut down its primate research center over the next 2 years, reported ScienceInsider. The school cited the “increasingly challenging” federal funding environment as the reason behind decision, with no mention of the recent investigations into the center’s animal welfare practices.

Harvard said it would wind down operations at the New England Primate (NEPRC) Research Center in Southborough, Massachusetts, by 2015 rather than seek to renew the center’s 5-year grant from the National Institutes of Health (NIH). The center’s roughly 2,000 monkeys—mostly rhesus macaques and cotton-top tamarins—will be transferred to the NIH’s seven other national primate centers, and Harvard said none of the animals will be euthanized.

“We are in the early stages and focusing our attention on working with our faculty, staff, and the NIH in order to assure a transition that is orderly and respectful to all concerned, including the animals,” Gina Vild, a spokeswoman for the medical school, told The New York Times. The center currently employs 20 faculty members, 32 postdocs and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies